NCT04303494View on ClinicalTrials.gov

Predictive Value of Heart Rate Variability on Cardiorespiratory Events

CompletedOBSERVATIONAL

Enrollment

292

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

November 5, 2022

Study Completion Date

November 5, 2022

Conditions

Post-immunisation Apnoea and Bradycardia of Prematurity (AOP)

Interventions

BIOLOGICAL

immunisation

combined diphtheria, tetanus, acellular pertussis, poliomyelitis, hepatitis B, ± Haemophilus influenzae type B and simultaneous pneumococcus (PCV13) vaccination

Trial Locations (1)

4056

University Children's Hospital Basel UKBB, University of Basel, Basel

All Listed Sponsors

lead

University Hospital, Basel, Switzerland

OTHER

NCT04303494 - Predictive Value of Heart Rate Variability on Cardiorespiratory Events | Biotech Hunter | Biotech Hunter